Comment on: Acute renal insufficiency during telavancin therapy in clinical practice

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 5, 2012, Pages 1300-1301

  Pai, Manjunath P ^a  

^a ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

Acute kidney injury; Dosing; Nephrotoxicity; Obesity; Telavancin; Vancomycin

Indexed keywords

CREATININE; TELAVANCIN; VANCOMYCIN;

ACUTE KIDNEY FAILURE; AREA UNDER THE CURVE; BODY MASS; CLINICAL PRACTICE; CREATININE CLEARANCE; DOSE CALCULATION; DRUG CLEARANCE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; GLOMERULUS FILTRATION RATE; HUMAN; LETTER; MEDICATION ERROR; NEPHROTOXICITY; OBESITY; RECOMMENDED DRUG DOSE; RISK REDUCTION;

ACUTE KIDNEY INJURY; AMINOGLYCOSIDES; ANTI-INFECTIVE AGENTS; FEMALE; HUMANS; MALE;

EID: 84859599192     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks029     Document Type: Letter

References (6)

1. Marcos LA, Camins BC, Ritchie DJ et al. Acute renal insufficiency during telavancin therapy in clinical practice. J Antimicrob Chemother 2012; 67: 723-6.
2. Worboys P, Barriere SL. Population pharmacokinetic analysis suggests minimal impact of obesity on telavancin (TLV) exposure. In: Abstracts of the Fifty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, 2011. Abstract A1-1156. American Society for Microbiology, Washington, DC, USA.
3. Theravance, Inc. and Astellas Pharma US, Inc. VIBATIVw Prescribing Information. www.vibativ.com (20 December 2011, date last accessed).
4. Pai MP. Estimating the glomerular filtration rate in obese adult patients for drug dosing. Adv Chronic Kidney Dis 2010; 17: e53-62.
5. Dvorchik B, Arbeit RD, Chung J et al. Population pharmacokinetics of daptomycin. Antimicrob Agents Chemother 2004; 48: 2799-807.
6. Slover CM, Nkechi A, Barriere SL et al. Telavancin for treatment of complicated skin and skin structure infections in obese patients. In: Abstracts of the Fifty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, 2011. Abstract L1-1491. American Society for Microbiology, Washington, DC, USA.